Behind the glossy marketing and pharmaceutical assurances of GLP-1 medications lurks an underrecognized and potentially ...

Two landmark international studies led by Professor Ignacio Martin-Loeches have been recently published in The Lancet and Nature Medicine — placing Irish critical care research firmly on the global ...

Cecilia Bahit, MD, and Carolyn Lam, MBBS, PhD, FACC, discuss the barriers patients face when seeking access to clinical trial ...

In people with cancer, CBT-I may slightly improve insomnia severity, sleep quality, and most sleep diary parameters without introducing additional unwanted or harmful events. However, we are very ...

The debate over the most effective models for early childhood education is a longstanding one. While the benefits of ...

OPERA-02: a phase 3 randomized, double-blind, active-controlled study of palazestrant with ribociclib versus letrozole with ribociclib for the first-line treatment of ER+, HER2- advanced breast cancer ...

The convergence of ancient Indian healing wisdom and modern Western medical practice is creating unprecedented opportunities ...

In the field of genetic epidemiology, Mendelian Randomization (MR) has surfaced as a robust tool for assessing causal relationships between various ...

Deucravacitinib reduces circulating proteins associated with kidney dysfunction in patients with systemic lupus erythematosus, according to data presented at ACR Convergence 2025.“Specific plasma ...

New pooled data confirm that endovascular thrombectomy improves survival and function in large-core stroke, offering hope for ...

Diet and exercise were associated with improved psychologic symptoms among patients with moderate baseline symptoms, ...

Experts discuss the impact of dose escalation in treating neuroendocrine tumors, highlighting recent trials and collaborative research efforts for improved patient outcomes.